Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused on treating rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug ...

In modern healthcare, accurate and reliable diagnostic tools play a pivotal role in assessing bone health. One such advanced ...

Despite improvements in neuroblastoma treatment, survival figures lag behind those of many other childhood malignancies. New treatments, and better use of existing treatments, are essential to reduce ...

SimonMed Imaging and HeartLung Technologies are pleased to announce a strategic partnership to offer HeartLung's AI-enabled ...